{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:45:34Z","timestamp":1762875934532},"reference-count":29,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1080\/03007995.2017.1416347","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T19:32:10Z","timestamp":1513107130000},"page":"1261-1269","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis"],"prefix":"10.1080","volume":"34","author":[{"given":"Songkai","family":"Yan","sequence":"first","affiliation":[{"name":"GSK, US Health Outcomes & Epidemiology \u2013 Vaccines, Philadelphia, PA, USA;"},{"name":"Current affiliation: CSL Behring, King of Prussia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maral","family":"DerSarkissian","sequence":"additional","affiliation":[{"name":"Analysis Group Inc., Los Angeles, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel H.","family":"Bhak","sequence":"additional","affiliation":[{"name":"Analysis Group Inc., Boston, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Groupe d\u2019analyse, Lt\u00e9e \u2013 Analysis Group Inc., Montr\u00e9al, QC, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Sheng","family":"Duh","sequence":"additional","affiliation":[{"name":"Analysis Group Inc., Boston, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girishanthy","family":"Krishnarajah","sequence":"additional","affiliation":[{"name":"GSK, US Health Outcomes & Epidemiology \u2013 Vaccines, Philadelphia, PA, USA;"},{"name":"Current affiliation: CSL Behring, King of Prussia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"e_1_3_4_2_1","first-page":"95","article-title":"Noninfluenza vaccination coverage among adults \u2013 United States, 2012","volume":"63","author":"Williams WW","year":"2014","unstructured":"Williams WW, Lu PJ, O\u2019Halloran A, et\u00a0al. Noninfluenza vaccination coverage among adults \u2013 United States, 2012. Morb Mortal Wkly Rep 2014;63:95-102","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_4_3_1","first-page":"110","article-title":"Advisory Committee on Immunization Practices (ACIP); ACIP Adult Immunization Work Group, Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older \u2013 United States, 2014","volume":"63","author":"Bridges CB","year":"2014","unstructured":"Bridges CB, Coyne-Beasley T; Advisory Committee on Immunization Practices (ACIP); ACIP Adult Immunization Work Group, Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older \u2013 United States, 2014. Morb Mortal Wkly Rep 2014;63:110-12","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6611a1"},{"key":"e_1_3_4_5_1","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz R","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 2008;57:1-30","journal-title":"Morb Mortal Wkly Rep Recomm Rep"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.4065\/82.11.1341"},{"key":"e_1_3_4_7_1","first-page":"468","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older \u2013 Advisory Committee on Immunization Practices (ACIP), 2012","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older \u2013 Advisory Committee on Immunization Practices (ACIP), 2012. Morb Mortal Wkly Rep 2012;61:468-70","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_4_8_1","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales CM","year":"2014","unstructured":"Hales CM, Harpaz R, Ortega-Sanchez I, et\u00a0al. Update on recommendations for use of herpes zoster vaccine. Morb Mortal Wkly Rep 2014;63:729-31","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072723"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067260"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10935-015-0394-3"},{"key":"e_1_3_4_12_1","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Morb Mortal Wkly Rep 2011;60:13-15","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_3_4_13_1","volume-title":"Reimbursement for Vaccines and Vaccine Administration Under Medicare Part D. (MLN Matters. no: SE077272013)","year":"2013","unstructured":"Reimbursement for Vaccines and Vaccine Administration Under Medicare Part D. (MLN Matters. no: SE077272013). Baltimore (MD): Centers for Medicare & Medicaid Services, 2013"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-9-201005040-00005"},{"key":"e_1_3_4_15_1","unstructured":"Wouters AV Manthe K Stone DA. Few Medicare Part D Plans Offer Vaccines Without Cost-Sharing. Available at: https:\/\/www.manatt.com\/Insights\/Newsletters\/Health-Update\/HIPAA-and-Emerging-Technologies#Article5 [Last accessed 24 October 2017]"},{"key":"e_1_3_4_16_1","unstructured":"TransactRx. Simplifying Vaccine Billing. POC Network Technologies Inc. 2014. Available at: http:\/\/www.transactrx.com\/ [Last accessed 5 January 2015]"},{"key":"e_1_3_4_17_1","unstructured":"Stoecker C Stewart A Lindley M. Cost of cost-sharing: the impact of Medicaid benefit design on vaccination coverage rates. Abstract presented at: APHA 142nd Annual Meeting & Expo New Orleans LA USA 15\u201319 November 2014"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.27.1.103"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2006.03.021"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-442"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(00)00263-4"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.08.014"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.00585.x"},{"key":"e_1_3_4_24_1","unstructured":"Medicare: Many Factors Including Administrative Challenges Affect Access to Part D Vaccinations. (No. GAO-12-61.) U.S. Government Accountability Office 2011"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2332"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/522153"},{"key":"e_1_3_4_27_1","first-page":"195","article-title":"Patient factors associated with following a relocated primary care provider among older adults","volume":"15","author":"Gozu A","year":"2009","unstructured":"Gozu A, Nidiry MA, Ratanawongsa N, et\u00a0al. Patient factors associated with following a relocated primary care provider among older adults. Am J Manag Care 2009;15:195-200","journal-title":"Am J Manag Care"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00365-2"},{"key":"e_1_3_4_29_1","unstructured":"Murrin S. State Standards for Access to Care in Medicaid Managed Care. (No. OEI-02-11-00320.) Washington (DC): US Office of Inspector General Department of Health and Human Services 2014"},{"key":"e_1_3_4_30_1","unstructured":"Yen W. How Long and How Far Do Adults Travel and Will Adults Travel for Primary Care? (Washington State Health Services Research Project Research Brief no. 70.) Washington (WA): Washington State Office of Financial Management 2013"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2017.1416347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T05:51:01Z","timestamp":1716357061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2017.1416347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,3]]}},"alternative-id":["10.1080\/03007995.2017.1416347"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2017.1416347","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}